Publicaciones en colaboración con investigadoras/es de Massachusetts General Hospital (34)

2023

  1. Cerebrolysin Attenuates Exacerbation of Neuropathic Pain, Blood-spinal Cord Barrier Breakdown and Cord Pathology Following Chronic Intoxication of Engineered Ag, Cu or Al (50–60 nm) Nanoparticles

    Neurochemical Research, Vol. 48, Núm. 6, pp. 1864-1888

  2. Prognostic Models for Global Functional Outcome and Post-Concussion Symptoms Following Mild Traumatic Brain Injury: A Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) Study

    Journal of Neurotrauma, Vol. 40, Núm. 15-16, pp. 1651-1670

2022

  1. Health care utilization and outcomes in older adults after Traumatic Brain Injury: A CENTER-TBI study

    Injury, Vol. 53, Núm. 8, pp. 2774-2782

  2. Measurement invariance of six language versions of the post-traumatic stress disorder checklist for DSM-5 in civilians after traumatic brain injury

    Scientific Reports, Vol. 12, Núm. 1

  3. Neurocognitive correlates of probable posttraumatic stress disorder following traumatic brain injury

    Brain and Spine, Vol. 2

  4. Serum metabolome associated with severity of acute traumatic brain injury

    Nature Communications, Vol. 13, Núm. 1

2021

  1. Alzheimer's disease neuropathology is exacerbated following traumatic brain injury. Neuroprotection by co-administration of nanowired mesenchymal stem cells and cerebrolysin with monoclonal antibodies to amyloid beta peptide

    Progress in Brain Research (Elsevier B.V.), pp. 1-97

  2. Biomarkers for Traumatic Brain Injury: Data Standards and Statistical Considerations

    Journal of Neurotrauma, Vol. 38, Núm. 18, pp. 2514-2529

  3. Cerebrolysin restores balance between excitatory and inhibitory amino acids in brain following concussive head injury. Superior neuroprotective effects of TiO2 nanowired drug delivery

    Progress in Brain Research (Elsevier B.V.), pp. 211-267

  4. Global Characterisation of Coagulopathy in Isolated Traumatic Brain Injury (iTBI): A CENTER-TBI Analysis

    Neurocritical Care, Vol. 35, Núm. 1, pp. 184-196

  5. Histamine H3 and H4 receptors modulate Parkinson's disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy

    Progress in Brain Research (Elsevier B.V.), pp. 1-73

  6. Manganese nanoparticles induce blood-brain barrier disruption, cerebral blood flow reduction, edema formation and brain pathology associated with cognitive and motor dysfunctions

    Progress in Brain Research (Elsevier B.V.), pp. 385-406

  7. Methamphetamine exacerbates pathophysiology of traumatic brain injury at high altitude. Neuroprotective effects of nanodelivery of a potent antioxidant compound H-290/51

    Progress in Brain Research (Elsevier B.V.), pp. 123-193

  8. Nanodelivery of oxiracetam enhances memory, functional recovery and induces neuroprotection following concussive head injury

    Progress in Brain Research (Elsevier B.V.), pp. 139-230

  9. Nanodelivery of traditional Chinese Gingko Biloba extract EGb-761 and bilobalide BN-52021 induces superior neuroprotective effects on pathophysiology of heat stroke

    Progress in Brain Research (Elsevier B.V.), pp. 249-315

  10. Neuroprotective effects of insulin like growth factor-1 on engineered metal nanoparticles Ag, Cu and Al induced blood-brain barrier breakdown, edema formation, oxidative stress, upregulation of neuronal nitric oxide synthase and brain pathology

    Progress in Brain Research (Elsevier B.V.), pp. 97-121

  11. Primary versus early secondary referral to a specialized neurotrauma center in patients with moderate/severe traumatic brain injury: a CENTER TBI study

    Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine, Vol. 29, Núm. 1

  12. Superior antioxidant and anti-ischemic neuroprotective effects of cerebrolysin in heat stroke following intoxication of engineered metal Ag and Cu nanoparticles: A comparative biochemical and physiological study with other stroke therapies

    Progress in Brain Research (Elsevier B.V.), pp. 301-348

  13. Topical application of CNTF, GDNF and BDNF in combination attenuates blood-spinal cord barrier permeability, edema formation, hemeoxygenase-2 upregulation, and cord pathology

    Progress in Brain Research (Elsevier B.V.), pp. 357-376

2020

  1. Cerebrolysin enhances spinal cord conduction and reduces blood-spinal cord barrier breakdown, edema formation, immediate early gene expression and cord pathology after injury

    Progress in Brain Research (Elsevier B.V.), pp. 397-438